Yestar Healthcare Holdings Company Limited: Update following 2016 full-year results
CORPORATES CREDIT OPINION 22 March 2017 Update RATINGS Yestar Healthcare Holdings Company Limited Domicile China Long Term Rating Ba3 Type LT Corporate Family Ratings Outlook Stable Please see the ratings section at the end of this report for more information. The ratings and outlook shown reflect information as of the publication date. Contacts Gloria Tsuen, CFAYestar Healthcare Holdings Company Limited., formerly Yestar International Holdings Company Limited is an investment holding company principally engaged in the manufacture and sale of medical imaging products. The Company operates its business through two segments. The Imaging Printing Products segment is engaged in the manufacture and sale of color photographic paper, industrial Non Destructive Testing (NDT) x-ray films and the trading of imaging equipment. The Medical Products and Equipment segment is engaged in the manufacture and sale of medical dry films, medical wet films and dental films and the sale of medical equipment and reagents.
Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:
- 130 countries
11,000 corporate issuers
21,000 public finance issuers
76,000 structured finance obligations
Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.
Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.